Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0212-2022Class II

THERAKOS CELLEX Photopheresis Procedural Kit

Therakos Inc / initiated 2021-10-04 / Open, Classified

Therakos, Inc. began a recall of THERAKOS CELLEX Photopheresis Procedural Kit PRODUCT CODE: CLXUSA on . FDA classified it as Class II and gives the reason as "Product was released prior to all testing being completed. If used and a drive tube leak were to occur, may cause illness or injury". As of , the recall status on record is Open, Classified.

Recall record

Recall number
Z-0212-2022
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Therakos Inc
Product
THERAKOS CELLEX Photopheresis Procedural Kit PRODUCT CODE: CLXUSA
Product code
LNR System, Photopheresis, Extracorporeal
Reason for recall
Product was released prior to all testing being completed. If used and a drive tube leak were to occur, may cause illness or injury.
FDA root cause
Under Investigation by firm
Action
Mallincrodt intiated recall by telephone on 10/04/21 and by follow-up letter. Letter states reason for recall, health risk and action to take: If you are receiving this notification, you have been identified as a customer who received CELLEX Procedural Kit Lot #K307. Immediately examine your inventory and quarantine the product subject to this recall. Mallinckrodt Pharmaceuticals will provide you with a pre-paid shipping label to return it to the Mallinckrodt Pharmaceuticals warehouse. If you have any questions regarding the return of the recalled product, please contact Mallinckrodt Pharmaceuticals at (877) 566-9466 to receive further instructions. This recall is being carried out to the direct customer level. Your assistance is appreciated. Please complete and return the enclosed response form as soon as possible.
Quantity in commerce
Five (5) Cases -3 Kits/Case= 15 Kits
Distribution
IL
Product codes and lots
LOT # K307 EXPIRATION DATE: 2023-02-01 UDI: (01)20705030200003(10)K307(17)230201

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0212-2022
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0212-2022Class IIOngoingVoluntary: Firm initiated